Cart
sales@molnova.com
α-D-Galactose-1-phosphate Dipotassium Pentahydrate
CAS No. 19046-60-7
α-D-Galactose-1-phosphate Dipotassium Pentahydrate( Galactose 1-phosphate Potassium salt )
Catalog No. M19896 CAS No. 19046-60-7
Galactose 1-phosphate is an intermediate in the galactose metabolism and nucleotide sugars metabolism pathways.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 33 | In Stock |
|
| 25MG | 50 | In Stock |
|
| 50MG | 71 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Nameα-D-Galactose-1-phosphate Dipotassium Pentahydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionGalactose 1-phosphate is an intermediate in the galactose metabolism and nucleotide sugars metabolism pathways.
-
DescriptionGalactose 1-phosphate is an intermediate in the galactose metabolism and nucleotide sugars metabolism pathways.
-
In Vitro——
-
In Vivo——
-
SynonymsGalactose 1-phosphate Potassium salt
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number19046-60-7
-
Formula Weight426.39
-
Molecular FormulaC6H21K2O14P
-
Purity>98% (HPLC)
-
SolubilityH2O:125 mg/mL (371.67 mM; Need ultrasonic)
-
SMILESO.O.O.O.O.[K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.McCorvie TJ et al. The structural and molecular biology of type I galactosemia: Enzymology of galactose 1-phosphate uridylyltransferase. IUBMB Life. 2011 Sep;63(9):694-700.
molnova catalog
related products
-
3-(4-Hydroxyphenyl)-...
3-(4-hydroxyphenyl)-1-propanol is a member of the class of compounds known as 1-hydroxy-2-unsubstituted benzenoids.
-
Hexyl Octanoate
Hexyl Octanoate (FEMA 2575) is a RIFM fragrance.
-
MSC-4106
MSC-4106, an orally active and potent YAP/TAZ-TEAD inhibitor, disrupts TEAD1 and TEAD3 auto-palmitoylation and demonstrates significant efficacy in the NCI-H226 tumor xenograft model .
